about
Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adultsRapid and sensitive ultra-high-pressure liquid chromatography method for quantification of antichagasic benznidazole in plasma: application in a preclinical pharmacokinetic study.Population pharmacokinetics of benznidazole in adult patients with Chagas disease.Preclinical monitoring of drug association in experimental chemotherapy of Chagas' disease by a new HPLC-UV method.Benznidazole Extended-Release Tablets for Improved Treatment of Chagas Disease: Preclinical Pharmacokinetic Study.Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas DiseasePediatric clinical pharmacology studies in Chagas disease: focus on Argentina.New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice.Computational models to assign biopharmaceutics drug disposition classification from molecular structure.Experimental and Clinical Treatment of Chagas Disease: A Review.Identification of N-benzylacetamide as a major component of human plasmatic metabolic profiling of benznidazole.Hypoxia-activated cytotoxicity of benznidazole against clonogenic tumor cells.Ergosterol biosynthesis and drug development for Chagas disease.CB 1954 revisited. I. Disposition kinetics and metabolism.Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease.A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas diseaseEvaluation of compliance to congenital Chagas disease treatment: results of a randomised trial in BoliviaLimited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease
P2860
Q28539049-EEC72EB6-BEB9-4E35-A282-C37F97FDA6CFQ35450419-FF007A49-A8C5-4B62-9714-0F8304EB52B5Q35607812-ABBA7C4B-5B6F-4513-9335-4790B033FDEEQ36018865-438BDA55-7CE8-4351-8CF1-5D6D4F66D08BQ36729990-051E0235-B850-4218-A8E4-65DBAD76C9A3Q36933398-5F6CC5B9-42DF-4E6D-A46F-58A4FA16F96DQ37363965-DD55C8C4-7073-49AF-A90A-72F689BBD3C9Q37395315-E7BF5DEA-F487-4AAC-BE0B-82FFCBA4A62DQ39350243-F012BAC6-1999-4988-99F3-A4D37D33BAC7Q40175522-B033B00B-29E5-4D68-909B-9FB0D215FB10Q41989175-DC2D9F4D-1595-47C6-96C3-572CAC0F6AFDQ42220257-3FF68177-B500-4410-9692-9678A2C60BF4Q42945231-AFD504D2-0D13-43CE-AA29-F327C01EB9E7Q43276756-25DA5007-87A9-4620-9813-AD5E34C8A451Q44671235-49BB4E11-AD44-4FBA-8619-825B3C623CFFQ50088418-7F16124B-8AF5-4296-A5A0-7FF7404C2468Q56778752-9A50D84D-733D-484F-9F55-31CE4AC3AB26Q56829258-F3FC83C5-A195-4213-A804-349C97EB02FFQ58862886-AE858BC6-12ED-4A3A-BED8-2E1C9D8B0A1F
P2860
description
1984 nî lūn-bûn
@nan
1984 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Preclinical pharmacokinetics of benznidazole
@ast
Preclinical pharmacokinetics of benznidazole
@en
Preclinical pharmacokinetics of benznidazole
@nl
type
label
Preclinical pharmacokinetics of benznidazole
@ast
Preclinical pharmacokinetics of benznidazole
@en
Preclinical pharmacokinetics of benznidazole
@nl
prefLabel
Preclinical pharmacokinetics of benznidazole
@ast
Preclinical pharmacokinetics of benznidazole
@en
Preclinical pharmacokinetics of benznidazole
@nl
P2093
P2860
P356
P1476
Preclinical pharmacokinetics of benznidazole
@en
P2093
M I Walton
P R Twentyman
P2860
P2888
P304
P356
10.1038/BJC.1984.176
P407
P577
1984-09-01T00:00:00Z
P5875
P6179
1012258159